Featured Article
Academic Journal
Main Category: Alzheimer's \/ Dementia
Also Included In: Genetics; Biology \/ Biochemistry
Article Date: 12 Feb 2012 - 0:00 PST <\/p>\n
email to a friend printer friendly opinions <\/p>\n
<\/p>\n
Current Article Ratings: <\/p>\n
Patient \/ Public: Healthcare Prof: <\/p>\n
3 (1 votes) <\/p>\n
New research led by Nottingham University in the UK suggests abnormal levels of seven proteins in spinal fluid could be markers for the early stages of Alzheimer's disease, raising hopes of a test for a disease that is difficult to diagnose at the beginning. The researchers write about their findings in the Journal of Alzheimer's Disease. <\/p>\n
Study co-author Dr Kevin Morgan, professor of Human Genomics and Molecular Genetics at Nottingham, told the press on Tuesday that the findings are \"a new lead for improving early diagnosis of Alzheimer's disease\". <\/p>\n
An early diagnosis of Alzheimer's disease would help people prepare for the future and also enable them to be involved in clinical trials at a much earlier stage of the disease, when treatments are more likely to show positive results, he added. <\/p>\n
About 820,000 people in the UK have dementia, of which Alzheimer's disease is the most common form. Dementia often develops slowly and is not always obvious in the early stages. It can be difficult to distinguish from the mild forgetfulness often seen in normal ageing. <\/p>\n
Morgan and colleagues compared samples of cerebrospinal fluid (CSF) from 33 people with Alzheimer's disease, 10 people with mild cognitive impairment, and 20 healthy older people. Mild cognitive impairment is a condition where people have problems with thinking and memory but not to an extent that it interferes with everyday life. <\/p>\n
They compiled profiles of the proteins in each sample and then compared them with each other to see if they could find something distinctive in the samples from people with Alzheimer's disease. <\/p>\n
The results showed that the samples from people with Alzheimer's diseases tended to have higher levels of four proteins, and lower levels of three other proteins. <\/p>\n
A protein called SPARCL1 proved to be the strongest predictor for Alzheimer's. When the researchers tested the samples using only this protein, they could tell whether a person had Alzheimer's disease to an accuracy of 65%. <\/p>\n
This accuracy went up to 95% when they tested for abnormal levels of all seven proteins. <\/p>\n
The researchers repeated the tests with a new set of CSF samples from 32 healthy people and 30 people with Alzheimer's disease. This time, when they tested for all seven proteins, the accuracy was 85%. <\/p>\n
The team now plans to use their findings to develop a blood test for an early diagnosis of Alzheimer's disease. <\/p>\n
Morgan said: <\/p>\n
\"It will also be important to investigate what causes these specific proteins to change as Alzheimer's develops.\" <\/p>\n
By understanding the underlying changes in the biochemistry of Alzheimer's, we have a better chance of developing new treatments, he said, adding that: <\/p>\n
\"Dementia can only be defeated through research, and I hope these findings could take us a step closer to that goal.\" <\/p>\n
Dr Marie Janson, Director of Development at Alzheimer's Research UK, who part-funded the study, said the findings have \"opened up a new avenue for research\". <\/p>\n
She emphasized how difficult it is to diagnose Alzheimer's, as memory problems can be symptomatic of various conditions. <\/p>\n
\"This study has the potential to help create a vital tool for doctors to identify patients that need further investigation - but these results must now be followed up in order to achieve that goal,\" she added. <\/p>\n
Funds from the Big Lottery Fund and the EU FP6 Program through BIOPATTERN also supported the work. <\/p>\n
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today <\/p>\n
Visit our alzheimer's \/ dementia section for the latest news on this subject. \"Identification of SPARC-like 1 Protein as Part of a Biomarker Panel for Alzheimer's Disease in Cerebrospinal Fluid\"; Baharak Vafadar-Isfahani, Graham Ball, Clare Coveney, Christophe Lemetre, David Boocock, Lennart Minthon, Oskar Hansson, Amanda Kathleen Miles, Sabina M Janciauskiene, Donald Warden, A. David Smith, Gordon Wilcock, Noor Kalsheker, Robert Rees, Balwir Matharoo-Ball and Kevin Morgan; Journal of Alzheimer's Disease Volume 28, Number 3, pp 625-636, 2012; DOI: 10.3233\/JAD-2011-111505; Link to Abstract.
Additional source: Alzheimer's Research UK Please use one of the following formats to cite this article in your essay, paper or report: <\/p>\n
MLA <\/p>\n
Catharine Paddock PhD. \"Hope For Early Alzheimer's Test In Spinal Fluid.\" Medical News Today. MediLexicon, Intl., 12 Feb. 2012. Web. APA <\/p>\n Please note: If no author information is provided, the source is cited instead. <\/p>\n Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information. <\/p>\n If you write about specific medications or operations, please do not name health care professionals by name. <\/p>\n All opinions are moderated before being included (to stop spam) <\/p>\n Contact Our News Editors <\/p>\n For any corrections of factual information, or to contact the editors please use our feedback form.<\/p>\n Please send any medical news or health news press releases to: <\/p>\n Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions. <\/p>\n See the original post here: Featured Article Academic Journal Main Category: Alzheimer's \/ Dementia Also Included In: Genetics; Biology \/ Biochemistry Article Date: 12 Feb 2012 - 0:00 PST email to a friend printer friendly opinions Current Article Ratings: Patient \/ Public: Healthcare Prof: 3 (1 votes) New research led by Nottingham University in the UK suggests abnormal levels of seven proteins in spinal fluid could be markers for the early stages of Alzheimer's disease, raising hopes of a test for a disease that is difficult to diagnose at the beginning. The researchers write about their findings in the Journal of Alzheimer's Disease. Study co-author Dr Kevin Morgan, professor of Human Genomics and Molecular Genetics at Nottingham, told the press on Tuesday that the findings are \"a new lead for improving early diagnosis of Alzheimer's disease\" Continue reading
12 Feb. 2012. <http:\/\/www.medicalnewstoday.com\/articles\/241537.php><\/a>; <\/p>\n
Rate this article:
(Hover over the stars then click to rate) Patient \/ Public:
or Health Professional: <\/p>\n
<\/p>\n
\nHope For Early Alzheimer's Test In Spinal Fluid<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"